Company
Overview
Core Values
Executive Leadership
Services
Discovery & Preclinical
Pharmacology Services
Drug Safety Assessment
General Toxicology
Safety Pharmacology
Genetic Toxicology
Early Clinical Research (Phase 0 – IIa)
Phase I-IIa
Bioequivalence Studies
Seamless Data Integration
Pharmacokinetics / Pharmacodynamics
Bioanalytical Services
Small Molecule Bioanalysis
Large Molecule Bioanalysis
Validated Assays
Development & Regulatory Services
Drug Development
Biopharmaceutical Development
Regulatory Affairs
Program Management
Quality Assurance Services
Cardiac Safety Center of Excellence
List A-Z
List by Location
Locations
All Locations
Executive Offices
Discovery & Preclinical
Early Clinical Research
Bioanalytical Services
Scientific Library
Case Studies
Podcasts
Posters
Webinars
White Papers
Events
News
Contact Us
Study Participation
Medical Investigators
Careers at MDS
MDS Pharma Services News
February 10, 2010
MDS Announces Agreements to Divest MDS Pharma Services Early Stage Business
January 10, 2010
MDS Pharma Services Uses SAS® Drug Development to Help Take Sponsor-CRO Collaboration to Next Level
Upcoming Events
March 8, 2010 - March 12, 2010
Salt Lake City, Utah
Society of Toxicology 49th Annual Meeting
March 17, 2010 - March 20, 2010
Atlanta, Georgia
ASCPT - American Society of Clincal Pharmacology and Therapeutics
Home
/
Services
/
Early Clinical Research
/
PK/PD
/
Modeling and Simulation
Modeling and Simulation
MDS Pharma Services’ pharmacokinetic scientists conduct a variety of pharmacokinetic analyses, including PK/PD, clinical trial simulation, sparse sampling strategies, population PK analysis, parametric and nonparametric population PK/PD analysis. In recent years regulatory agencies have encouraged the use of modeling and simulation as methods of accelerating drug development programs. MDS Pharma Services recognizes the need to use pharmaco-statistical models to aid in decision making processes. We can tailor a project to your specific needs and objectives while controlling costs. We have experience in submitting these analyses to regulatory agencies, and working with you to ensure your submission is complete.
Early Clinical Research
Phase I-IIa
Bioequivalence Studies
Seamless Data Integration
PK/PD
SAS® Drug Development
Study Design and Protocol Development
Data Management
Statistical Analysis
PK/PD Analysis
Medical Writing and Reporting
Modeling and Simulation
Consultation
© 2009 MDS Pharma Services |
Corporate Governance
|
Legal
|
Privacy
|
Site Map